Lumos Pharma Inc (LUMO)

Finanzdaten der Lumos Pharma Inc-Aktie (LUMO)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	80.02% 0.165	0.826	0.007	0.527	0.691
Operating Expenses	1.82% 11.03	10.83	8.939	10.17	8.726
Benefits Costs and Expenses	100.00% -	10.28	8.307	9.487	-
Costs And Expenses	7.24% 11.03	10.28	8.307	9.487	8.726
Operating Income/Loss	8.58% -10.86	-10.00	-8.932	-9.643	-8.035
Nonoperating Income/Loss	23.03% 0.421	0.547	0.632	0.683	0.689
Income/Loss From Continuing Operations Before Tax	101.74% 0.165	-9.457	-8.30	-8.96	-7.346
Income Tax Expense/Benefit	-	-	-	-0.029	-
Income/Loss From Continuing Operations After Tax	10.40% -10.44	-9.457	-8.30	-8.931	-7.346
Net Income/Loss	10.40% -10.44	-9.457	-8.30	-8.931	-7.346
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	48,490% 8.1049	-0.0167	7.9785	8.1646	8.2399
Diluted Average Shares	48,490% 8.1049	-0.0167	7.9785	8.1646	8.2399
Basic Earnings Per Share	10.26% -1.29	-1.17	-1.04	-1.09	-0.89
Diluted Earnings Per Share	10.26% -1.29	-1.17	-1.04	-1.09	-0.89
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-